TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
Open for tender
Official procurement procedure

Quantity Surveyor/Contract Administrator/BSL3 Laboratory – Full and complete service for the duration of the project life cycle Validation Centre

Architectural
construction
engineering and inspection services
+1 more
North West (UKD62)
Published value
£55,000
Submission deadline 30 Apr 2021, 12:00 BST
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: Medicines Discovery Catapult: "Quantity Surveyor/Contract Administrator/BSL3 Laboratory – Full and complete service for the duration of the project life cycle Validation Centre". Published status: active. Published value: £55,000. 1 published lot. Recorded submission deadline: 30 Apr 2021, 12:00 BST. See the official notice for participation instructions.
Contracting AuthorityMedicines Discovery CatapultScope & CategoriesNot publishedSubmission Window
Closed
30 Apr 2021, 12:00 BST
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)£55,000
Bidder Intelligence · Authority Profile: Medicines Discovery Catapult
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for Medicines Discovery Catapult. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Average Price Reduction
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
3.5Bids / Report
33.3% of reports have one bid
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 8 active published awards; 6 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Price reduction compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityMedicines Discovery Catapult
Procedure methodNot published
Procurement categoryNot published
Statusactive
Framework / DPSNot published
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published9 Apr 2021, 08:53 BST
Last source update9 Apr 2021, 08:53 BST
Recurring procurementNo
ClassificationArchitectural, construction, engineering and inspection services, Construction work
Delivery area
North West (UKD62)
OCIDocds-h6vhtk-02a415
What is being bought
Medicines Discovery Catapult (MDC) is a national facility for collaborative R&D exploring and developing new approaches to the discovery and proof of well targeted medicines, diagnostics and biomarkers. Funded by Innovate UK, an agency of the UK government, MDC are an independent not-for-profit company bringing together a fragmented UK sector of industry, academia, charities, technologists, services, finance companies, SMEs and start-ups who together can turn good science into new, high value products. By sharing problems, rare expertise and assets we support the growth of this new community through a time of radical business and national change. Capitalising on the success of the Lighthouse Lab to create a new BSL3 facility for innovative diagnostics, biomarkers and complex medicines and develop the UK’s onshore diagnostic capability and capacity and the associated supply chain. The project will create a national facility for testing and validation of new diagnostics, biomarkers and innovative therapeutics for disease. The Validation Centre of Excellence will enable innovators to set up new companies with confidence, driving regional growth in high-value jobs and a sector of urgent national and global need. The Centre will build on the Lighthouse brand, creating a hub for new diagnostic and therapeutic validation. Quantity Surveyor: Further information can be found at https://procontract.due-north.com/RFx/RFxSummary?rfxId=0371ffc1-0099-eb11-810c-005056b64545&projectId=ab54220f-7c98-eb11-810c-005056b64545
What changed
From the official release history
  1. Published value updated to £55,000
    9 Apr 2021, 08:53 BST
  2. Status changed to active
    9 Apr 2021, 08:53 BST
  3. Official notice release published
    9 Apr 2021, 08:53 BST
  4. Submission deadline changed to 30 Apr 2021, 12:00 BST
    9 Apr 2021, 08:53 BST
  5. Buyer information updated
    9 Apr 2021, 08:53 BST
Lots and requirements (1)
Published by the contracting authority
  • Lot 1 · #1
    Individual lot title not published
    active
    Published value£55,000
    Medicines Discovery Catapult (MDC) is a national facility for collaborative R&D exploring and developing new approaches to the discovery and proof of well targeted medicines, diagnostics and biomarkers. Funded by Innovate UK, an agency of the UK government, MDC are an independent not-for-profit company bringing together a fragmented UK sector of industry, academia, charities, technologists, services, finance companies, SMEs and start-ups who together can turn good science into new, high value products. By sharing problems, rare expertise and assets we support the growth of this new community through a time of radical business and national change. Capitalising on the success of the Lighthouse Lab to create a new BSL3 facility for innovative diagnostics, biomarkers and complex medicines and develop the UK’s onshore diagnostic capability and capacity and the associated supply chain. The project will create a national facility for testing and validation of new diagnostics, biomarkers and innovative therapeutics for disease. The Validation Centre of Excellence will enable innovators to set up new companies with confidence, driving regional growth in high-value jobs and a sector of urgent national and global need. The Centre will build on the Lighthouse brand, creating a hub for new diagnostic and therapeutic validation. Quantity Surveyor: Further information can be found at https://procontract.due-north.com/RFx/RFxSummary?rfxId=0371ffc1-0099-eb11-810c-005056b64545&projectId=ab54220f-7c98-eb11-810c-005056b64545
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    9 Apr 2021, 08:53 BST
  2. Submission deadline
    30 Apr 2021, 12:00 BST
Commercial outcome and competition
AwardsNo award published
ContractsNo contract published
Bid statisticsNo aggregate bid statistics published
Buyer and organisations in this procedure

Medicines Discovery Catapult

Contracting authority GB-FTS-1022
View buyer profile
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published